Exchange: NASDAQ·Updated 12:46 PM EDT
XGN logo

XGN Exagen Inc

$7.46
$0.05
(0.67%)
Today
Reported EarningsAug 4
Mkt Cap$181.93M
Vol123,980.00

About XGN

Exagen, Inc. is a commercial-stage diagnostics company, which engages in transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention. It operates under the Avise brand. The company was founded by Waneta C. Tuttle and Cole Harris in 2002 and is headquartered in Vista, CA.
46

Neutral Sentiment

How do you feel about XGN?

Advertisement|Remove ads.